The emerging era of pharmacogenomics: current successes, future potential, and challenges.
Clin Genet
; 86(1): 21-8, 2014 Jul.
Article
en En
| MEDLINE
| ID: mdl-24684508
ABSTRACT
The vast range of genetic diversity contributes to a wonderful array of human traits and characteristics. Unfortunately, a consequence of this genetic diversity is large variability in drug response between people, meaning that no single medication is safe and effective in everyone. The debilitating and sometimes deadly consequences of adverse drug reactions (ADRs) are a major and unmet problem of modern medicine. Pharmacogenomics can uncover associations between genetic variation and drug safety and has the potential to predict ADRs in individual patients. Here we review pharmacogenomic successes leading to changes in clinical practice, as well as clinical areas probably to be impacted by pharmacogenomics in the near future. We also discuss some of the challenges, and potential solutions, that remain for the implementation of pharmacogenomic testing into clinical practice for the significant improvement of drug safety.
Palabras clave
Texto completo:
1
Colección:
01-internacional
Banco de datos:
MEDLINE
Asunto principal:
Farmacogenética
/
Variación Genética
/
Pruebas Genéticas
/
Biomarcadores Farmacológicos
/
Medicina de Precisión
Tipo de estudio:
Prognostic_studies
Límite:
Humans
Idioma:
En
Revista:
Clin Genet
Año:
2014
Tipo del documento:
Article
País de afiliación:
Canadá